breast cancer

Patient-Reported Outcomes with Neoadjuvant vs Adjuvant Systemic Therapy for Operable Breast Cancer
N Zdenkowski, P Butow, A Spillane, C Douglas, K Snook, M Jones, C Oldmeadow, S Fewster, C Beckmore, FM Boyle
Cite
The Intron 3 16 Bp Duplication Polymorphism of P53 (Rs17878362) Is Not Associated with Increased Risk of Developing Triple-Negative Breast Cancer
BC Morten, S Chiu, C Oldmeadow, J Lubinski, RJ Scott, KA Avery-Kiejda
Cite